Physician profile

Elizabeth Mcrae

Boerne, TX

NPI 1548253826

$14,365.57

in general payments reported to CMS, 2019-2025

7 companies · $1,461 in 2025

The $1,461 reported for 2025 was more than what 91% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,973.55
Food and Beverage$1,826.08

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Allergan, INC. $8,141.48 2019-2023
Abbvie INC. $5,025.98 2023-2025
Merz North America, INC. $1,043.49 2019-2024 Xeomin
Revance Therapeutics, INC. $78.11 2024 Daxxify
Paratek Pharmaceuticals, INC. $33.37 2021-2022
Solta Medical, A Division of Bausch Health US, LLC $22.66 2025 Clear+Brilliant
Amgen INC. $20.48 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Elizabeth Mcrae

$14,365.57

in general payments reported 2019-2025

Years
2019-2025
Top company
Allergan, INC.
Context
The $1,461 reported for 2025 was more than what 91% of providers received nationally.

https://glasscript.com/doctor/114991/elizabeth-mcrae

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.